DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,716,797 | +97249.3% | 14,981 | -5.8% | 0.11% | -0.9% |
| Q2 2023 | $3,818 | -12.3% | 15,907 | -7.9% | 0.11% | -19.6% |
| Q1 2023 | $4,355 | -1.5% | 17,277 | +3.7% | 0.14% | -7.4% |
| Q4 2022 | $4,422 | -99.9% | 16,660 | -8.4% | 0.15% | -14.9% |
| Q3 2022 | $4,696,000 | +3.5% | 18,179 | +1.6% | 0.18% | +8.0% |
| Q2 2022 | $4,536,000 | -16.2% | 17,895 | -3.0% | 0.16% | -3.0% |
| Q1 2022 | $5,413,000 | +0.7% | 18,454 | +13.0% | 0.17% | +4.4% |
| Q4 2021 | $5,375,000 | +7.2% | 16,334 | -0.8% | 0.16% | -4.2% |
| Q3 2021 | $5,012,000 | +10.7% | 16,464 | -2.4% | 0.17% | +11.3% |
| Q2 2021 | $4,528,000 | +29.1% | 16,876 | +8.3% | 0.15% | +23.0% |
| Q1 2021 | $3,508,000 | +9.1% | 15,586 | +7.7% | 0.12% | -0.8% |
| Q4 2020 | $3,214,000 | +8.4% | 14,469 | +5.1% | 0.12% | -3.9% |
| Q3 2020 | $2,964,000 | +20.9% | 13,766 | -0.7% | 0.13% | +7.6% |
| Q2 2020 | $2,452,000 | +24.1% | 13,864 | -2.9% | 0.12% | +1.7% |
| Q1 2020 | $1,976,000 | +4.6% | 14,280 | +15.9% | 0.12% | +30.0% |
| Q4 2019 | $1,890,000 | +4.1% | 12,316 | -2.0% | 0.09% | -4.3% |
| Q3 2019 | $1,815,000 | +20.1% | 12,570 | +18.9% | 0.09% | +13.3% |
| Q2 2019 | $1,511,000 | +16.6% | 10,572 | +7.7% | 0.08% | +10.7% |
| Q1 2019 | $1,296,000 | +20.3% | 9,819 | -5.9% | 0.08% | +8.7% |
| Q4 2018 | $1,077,000 | -1.2% | 10,438 | +4.1% | 0.07% | +13.1% |
| Q3 2018 | $1,090,000 | +9.1% | 10,030 | -0.9% | 0.06% | 0.0% |
| Q2 2018 | $999,000 | +16.4% | 10,119 | +15.5% | 0.06% | +3.4% |
| Q1 2018 | $858,000 | +6.2% | 8,762 | +0.6% | 0.06% | +9.3% |
| Q4 2017 | $808,000 | +10.4% | 8,710 | +2.1% | 0.05% | +3.8% |
| Q3 2017 | $732,000 | +0.8% | 8,534 | -0.9% | 0.05% | -3.7% |
| Q2 2017 | $726,000 | -1.8% | 8,613 | -0.3% | 0.05% | -3.6% |
| Q1 2017 | $739,000 | +43.8% | 8,640 | +31.0% | 0.06% | +36.6% |
| Q4 2016 | $514,000 | -4.8% | 6,597 | -4.2% | 0.04% | -10.9% |
| Q3 2016 | $540,000 | -20.7% | 6,884 | +2.2% | 0.05% | -23.3% |
| Q2 2016 | $681,000 | +20.7% | 6,737 | +13.4% | 0.06% | +13.2% |
| Q1 2016 | $564,000 | +13.9% | 5,943 | +11.7% | 0.05% | +15.2% |
| Q4 2015 | $495,000 | -6.4% | 5,322 | -14.2% | 0.05% | -23.3% |
| Q3 2015 | $529,000 | -5.9% | 6,206 | -5.5% | 0.06% | 0.0% |
| Q2 2015 | $562,000 | 0.0% | 6,569 | -0.8% | 0.06% | 0.0% |
| Q1 2015 | $562,000 | +7.3% | 6,625 | +8.4% | 0.06% | +7.1% |
| Q4 2014 | $524,000 | +14.9% | 6,111 | +1.8% | 0.06% | +7.7% |
| Q3 2014 | $456,000 | -9.0% | 6,003 | -5.7% | 0.05% | -8.8% |
| Q2 2014 | $501,000 | +2.9% | 6,364 | -2.0% | 0.06% | -5.0% |
| Q1 2014 | $487,000 | -2.0% | 6,496 | +0.8% | 0.06% | -7.7% |
| Q4 2013 | $497,000 | -1.6% | 6,442 | -11.4% | 0.06% | -16.7% |
| Q3 2013 | $505,000 | +4.6% | 7,273 | -4.7% | 0.08% | -1.3% |
| Q2 2013 | $483,000 | – | 7,632 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |